PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,576 stories, page 535 of 710

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07302347: A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07242469: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07151378: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07117630: An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07073547: A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07024732: A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07011732: A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06948955: Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

Study type: EXPANDED_ACCESS. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06526988: Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06336330: Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06037954: A Study of Mental Health Care in People With Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05995665: Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05947825: Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05859204: Impact of Exercise Groups on Patient Mental Health and Wellbeing in an Acute Psychiatric Inpatient Unit

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05789082: A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05712200: Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05487599: A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05467176: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05437588: Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05301842: Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04826757: Effectiveness of Coordinated Care to Reduce the Prolonged Disability Risk Among Patients Suffering From Low Back Pain in Primary Care

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04174742: Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03736590: Clinic-Based Financial Coaching and Family Health and Development

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03542578: Diagnosis of Fatty Liver With Outpatient Ultrasound

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01341145: Physical Fitness, Cardiovascular and Brain Health

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HLB Determined to Retry Liver Cancer Drug Approval: "Multiple Cases of FDA Approval After Three CRLs"

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Aribio secures 90 billion won from Fuxing as AR1001 nears phase 3 topline - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Over 100 food ingredients entered the US food supply without FDA safety reviews, report finds

MSNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

AstraZeneca Turns to China for Molecule That Might Top New Merck COPD Drug

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ascelia Pharma Defends Orviglance Trial After FDA Rejection, Shares Plunge 79% in 2026

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy) (NASDAQ:SLN)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA to adjust food safety measures

Taipei TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MMJ The Voice DEA Didn't Want to Hear From During Marijuana Rescheduling Hearings

Digital JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma rated speculative Buy ahead of key Phase 3 trial results in 2026 for depression drug HLP003.

PluangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA seizes Cadila Pharma's Rs 2.45 cr worth Aciloc stock; orders market recall over "deceptive" branding

India's News.NetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical marketplaces: How online platforms are changing drug purchasing

AOL.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Blood-Brain Barrier Crossed: Denali’s FDA Approval Unlocks Alzheimer’s Pipeline

Tech TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Sichuan Goldstone Asia Pharmaceutical, Inc. Class A – SZSE:300434

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETFs Investing in Anhui Huaren Health Pharmaceutical Co., Ltd. Class A Stocks

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Abivax’s obefazimod met primary endpoint in Phase III ABTECT trial

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Read News and Stories about Faculty of Pharmaceutical Medicine

OncodailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This biotech stock could surge 93% after a breakthrough in cancer treatment

Opening Bell DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Maharashtra FDA Flagged Cadila Pharmaceuticals for Branding Concerns

LatestLYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Orion stock reflects steady pharma strategy as Helsinki-listed drug maker leans on specialty medicin

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese drug manufacturer with CCP ties imported unauthorized GLP-1 drug ingredients

Washington ExaminerOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Flour Crisis Looms: Permit Dispute Threatens Supply in Rawalpindi and Islamabad

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A subsidiary product of Northeast Pharmaceutical (000597.SZ) has been newly included in the National Essential Medicines List (2026 Edition).

google_newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab stock reflects the biotech group's global oncology ambitions

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rs 2.45 crore worth of Aciloc 150+, 300+ seized in Maharashtra; FDA orders recall

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

We have better antihistamines

The Glendale StarOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Denecimig shows consistent safety and efficacy across age groups in hemophilia A trial

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Checkpoint Inhibitors Are Failing Recurrent GBM. This Phase 1 Trial Design May Explain Why They Keep Trying.

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How to Write a Biotech Internship Email in 2026? Templates, Examples & Expert Tips

BioTecNikaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Warns Against Three Cosmetics After Mercury, Lead Levels Exceed Safety Limits

Medical DialoguesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Maharashtra Cracks Down on Deceptive Drug Branding

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New research suggests high blood pressure drug telmisartan enhances efficacy of PARP inhibitors in cancer treatment

SSBCrackOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA seizes Cadila Pharma's Rs 2.45 cr worth Aciloc stock; orders market recall over "deceptive" branding

ANI NewsOriginal source